Amanda B Hummon

Title: Innovations in Colon Cancer Prognosis by Amanda B Hummon

Introduction

Amanda B Hummon is a prominent inventor based in Granger, Indiana, known for her significant contributions to the field of cancer research. She has been awarded three patents that focus on biomarkers and their applications in the prognosis and treatment of colon cancer. Her work aims to improve patient outcomes through innovative diagnostic methods.

Latest Patents

Hummon's latest patents include groundbreaking research on genetic biomarkers for left-side colon cancer (LCC) and right-side colon cancer (RCC). These patents disclose methods for using biomarkers to provide prognostic information regarding relapse-free survival probabilities in patients diagnosed with LCC or RCC. The inventions also present prognostic panels utilizing gene expression values of the biomarkers, along with computer-implemented methods for assessing relapse-free survival probabilities. Additionally, her patents describe a genetic method for classifying colon cancer tissues and provide stratification methodologies for assessing the risk of relapse in patients.

Career Highlights

Amanda B Hummon is affiliated with the University of Notre Dame Du Lac, where she conducts her research and develops her innovative solutions. Her work has garnered attention in the scientific community, contributing to advancements in cancer treatment and management.

Collaborations

Hummon collaborates with Steven Buechler, enhancing her research efforts and expanding the impact of her inventions in the medical field.

Conclusion

Amanda B Hummon's innovative work in the realm of colon cancer biomarkers represents a significant advancement in cancer prognosis and treatment strategies. Her contributions are poised to make a lasting impact on patient care and cancer management.